Neuroscience Research

Neuroscience research delves into the intricate workings of the brain and the nervous system, integrating multidisciplinary approaches to decipher various aspects from their development and structure to their function, and how they give rise to thought, emotion and behavior in health and disease, providing invaluable insights into the complexities of the human mind and body.

This expansive field addresses complex neurological and psychiatric conditions including Alzheimer's disease, Parkinson's disease, epilepsy, anxiety disorders, and neurodevelopmental disorders. A transformative milestone emerged with the development of a comprehensive human brain cell atlas. This initiative has systematically mapped over one million cells across 42 distinct neuroanatomical regions, delineating more than 100 molecularly defined cell types. The atlas provides unprecedented resolution into the cellular heterogeneity of the human brain, offering critical insights into the etiopathology of neuropsychiatric disorders such as schizophrenia and Alzheimer's disease.

Complementing this structural framework, recent advances in multimodal neurotechnologies — encompassing high-density electrophysiology, optogenetic interfaces, and microfluidic organoid platforms — now enable precise perturbation and interrogation of neural circuits. These integrated methodologies facilitate mechanistic investigations across scales, from single-cell dynamics to system-level connectivity. While extensively validated in animal models, these platforms are increasingly accessible to the neuroscience community, thereby accelerating mechanistic studies of neural circuitry and associated disease pathways.

To bridge these technological and structural insights, physiologically relevant cellular models are essential for functional validation. At AcceGen, we offer a robust suite of cellular tools designed to support and accelerate neuroscience research across diverse applications. For instance, primary neuronal cultures and induced pluripotent stem cell (iPSC)-derived neurons recapitulate neurodevelopmental and neurodegenerative processes with high fidelity. Immortalized neural cell lines provide standardized platforms for high-throughput screening, while engineered models incorporating disease-associated mutations enable targeted pathophysiological studies. Furthermore, molecular tools such as miRNA agomirs/antagomirs permit systematic investigation of post-transcriptional regulatory mechanisms in neural contexts. Collectively, these experimental systems support the deconvolution of neural circuit dysfunction and identification of novel therapeutic targets.

By integrating these advanced cellular models and tools, researchers can systematically unravel the pathobiology of neural circuit dysfunction, accelerate target validation and enhance the predictive validity of translational pipelines for neurological disorders. AcceGen promises to support the neuroscience community and advance our fundamental understanding of brain heterogeneity with high-quality products and services.